Welcome to our dedicated page for Grail SEC filings (Ticker: GRAL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
GRAIL, Inc. (Nasdaq: GRAL) files reports with the U.S. Securities and Exchange Commission that provide detail on its operations as a healthcare diagnostics company focused on multi-cancer early detection. On this page, you can review GRAIL’s SEC filings, including current reports on Form 8-K that describe material events such as private placements, equity distribution agreements, commercial leases, preliminary financial results, and strategic collaboration arrangements.
Recent 8-K filings outline securities purchase agreements for private placements of common stock and pre-funded warrants, a stock purchase agreement with Samsung-related entities tied to a planned business collaboration for commercialization of the Galleri test in Asia, and an equity distribution agreement that allows at-the-market offerings of common stock through designated sales agents. Other filings describe a long-term lease for a new corporate headquarters in Sunnyvale, California and the release of quarterly financial results, along with the company’s use of non-GAAP measures such as Adjusted Gross Profit (Loss) and Adjusted EBITDA.
Through these filings, investors can see how GRAIL structures its financings, the key terms of its strategic agreements, and selected information about its financial condition and operations. Stock Titan’s platform adds AI-powered summaries that explain the main points of each filing in plain language, highlight important sections, and help distinguish between one-time transactions and ongoing obligations. Users can also quickly locate information related to equity issuances, registration rights, and other matters that may affect existing or prospective shareholders.
GRAIL, Inc. director Steven Mizell received an equity-based compensation award instead of cash fees. He was granted 396 deferred stock units of common stock under the company’s deferred stock program and 2024 Incentive Award Plan, in lieu of $19,726.03 of director cash fees, based on a price of $49.79 per share, which was the closing price on April 15, 2026. The award vests immediately on the grant date, and following this grant he directly holds 37,071 shares of common stock. This transaction reflects a non-open-market grant/award acquisition rather than a market purchase.
CHASE WILLIAM J reported acquisition or exercise transactions in this Form 4 filing.
GRAIL, Inc. director William J. Chase received a grant of 408 shares of common stock in the form of deferred stock units. The award was issued under the company’s deferred stock program and 2024 Incentive Award Plan in lieu of $20,342.47 of cash director fees.
The grant was valued at $49.79 per share, equal to the closing price of GRAIL’s common stock on April 15, 2026, and vests immediately on the grant date. After this compensation-related award, Chase directly holds 37,211 shares of GRAIL common stock.
GRAIL, Inc. director Gregory L. Summe received an equity-based compensation award rather than cash fees. He acquired 631 deferred stock units valued at $49.79 per share, in lieu of $31,438.36 of director fees, under the company’s deferred stock program and 2024 Incentive Award Plan. The units vest immediately on the grant date, and following this grant he holds 39,754 shares of common stock directly.
GRAIL, Inc.’s Chief Financial Officer, Aaron Freidin, reported an automatic sale of 45,806 shares of common stock at a weighted average price of $49.9176 per share. According to the footnote, these were broker-executed “sell-to-cover” transactions to pay withholding taxes upon award vesting and share delivery. After these sales, Freidin directly holds 260,669 shares of GRAIL common stock.
GRAIL, Inc. director and Chief Executive Officer Robert P. Ragusa reported an automatic tax-related share sale. On the transaction date, an executing broker sold 123,502 shares of Common Stock in a sell-to-cover transaction to satisfy withholding taxes tied to award vesting and share delivery.
The broker executed the sales as part of a block trade at a weighted average price of $49.9176 per share. After these transactions, Ragusa directly holds 518,582 shares of GRAIL common stock, indicating he retains a substantial equity position despite the tax-driven sale.
GRAIL, Inc. President and director Joshua J. Ofman reported an automatic sale of common stock tied to tax withholding. An executing broker sold 61,665 shares in a sell-to-cover transaction following award vesting at a weighted average price of $49.9176 per share. After these sales, Ofman directly holds 371,216 shares of GRAIL common stock. The footnote explains the shares were sold to cover withholding taxes and executed as part of a block trade across multiple transactions.
Aaron Freidin submitted a Form 144 notice proposing to sell 79,460 shares of Common Stock acquired upon vesting of restricted stock units on 04/03/2026.
The filing also lists recent sales by Mr. Freidin during the prior three months: 9,573 shares sold on 03/02/2026, 655 shares on 03/05/2026, and 2,492 shares on 03/09/2026, with the recorded proceeds shown for each transaction.
Grayscale Analytics, Inc. reported Rule 144 transactions involving Common Stock. The filing lists 106,970 shares of Common Stock acquired upon vesting of restricted stock units under the issuer's equity incentive plans on 04/03/2026. It also discloses three sales by a reporting holder: 17,002, 690, and 2,937 shares on 03/02/2026, 03/05/2026, and 03/09/2026, respectively, with the dollar amounts shown alongside each sale. Shares outstanding are listed as 41,134,219 as of 04/06/2026.
Grayscale Alpha Group (GRAL) insider transactions disclosed under Rule 144. Director Robert P. Ragusa reported open-market dispositions of Common Stock: 37,504 shares on 03/02/2026 for $1,881,417.06, 980 shares on 03/05/2026 for $51,949.80, and 7,461 shares on 03/09/2026 for $357,296.13. The filing also reports 214,240 shares acquired upon vesting of restricted stock units on 04/03/2026 as compensation for services rendered.
GRAIL Inc ownership disclosure: The Vanguard Group filed an amendment stating it beneficially owns 0 shares (0%) of GRAIL Inc common stock. The filing explains an internal realignment on January 12, 2026 that disaggregated certain Vanguard subsidiaries and business divisions for SEC reporting; those entities will report separately under Release No. 34-39538. The amendment is signed by Ashley Grim, Head of Global Fund Administration, on 03/27/2026.